R.R. Donnelly & Sons (RRD) announced today that it used its supply chain capabilities to accelerate the delivery of rapid COVID-19 tests to the U.S.
The company, which specializes in helping medical device clients optimize their supply chain, said in a news release that it leveraged its ISO 13485 accredited facilities and ability to scale quickly to facilitate Siemens Healthineers’ time-sensitive effort to deliver its COVID-19 antigen self-tests to the U.S. market.
RRD and Siemens Healthineers collaborated to upscale with uncertain demand amid the COVID-19 pandemic. The company said that, during the omicron variant peak in January 2022, Siemens looked to make tens of millions of tests available to the U.S. through state, federal and local partnership efforts. It sought to expand warehouse space to meet the demand and accommodate the massive volumes of its product.
“It was critical to find a supplemental supply chain and warehouse solution that …